Annual Total Liabilities
$50.13 M
+$35.56 M+244.01%
31 December 2022
Summary:
Catalyst Biosciences annual total liabilities is currently $50.13 million, with the most recent change of +$35.56 million (+244.01%) on 31 December 2022. During the last 3 years, it has risen by +$35.56 million (+244.01%).CBIO Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$6.45 M
-$34.26 M-84.16%
30 September 2023
Summary:
Catalyst Biosciences quarterly total liabilities is currently $6.45 million, with the most recent change of -$34.26 million (-84.16%) on 30 September 2023.CBIO Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CBIO Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +244.0% | -55.8% |
| 5 y5 years | +65.9% | -78.7% |
CBIO Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -80.0% | -97.4% |
Catalyst Biosciences Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $6.45 M(-84.2%) |
| June 2023 | - | $40.71 M(-8.9%) |
| Mar 2023 | - | $44.70 M(-10.8%) |
| Dec 2022 | $50.13 M(+244.0%) | $50.13 M(+2949.5%) |
| Sept 2022 | - | $1.64 M(-61.9%) |
| June 2022 | - | $4.31 M(-67.3%) |
| Mar 2022 | - | $13.19 M(-9.5%) |
| Dec 2021 | $14.57 M(-22.4%) | $14.57 M(-18.1%) |
| Sept 2021 | - | $17.80 M(+7.1%) |
| June 2021 | - | $16.62 M(+10.9%) |
| Mar 2021 | - | $14.99 M(-20.2%) |
| Dec 2020 | $18.78 M(-37.9%) | $18.78 M(+5.8%) |
| Sept 2020 | - | $17.75 M(+20.5%) |
| June 2020 | - | $14.72 M(+12.9%) |
| Mar 2020 | - | $13.04 M(-56.8%) |
| Dec 2019 | $30.22 M(+507.4%) | $30.22 M(+187.2%) |
| Sept 2019 | - | $10.52 M(+35.5%) |
| June 2019 | - | $7.76 M(+28.2%) |
| Mar 2019 | - | $6.06 M(+21.7%) |
| Dec 2018 | $4.97 M(-43.1%) | $4.97 M(+43.6%) |
| Sept 2018 | - | $3.46 M(+34.4%) |
| June 2018 | - | $2.58 M(-15.0%) |
| Mar 2018 | - | $3.04 M(-65.3%) |
| Dec 2017 | $8.74 M(-60.3%) | $8.74 M(-8.1%) |
| Sept 2017 | - | $9.51 M(+2.4%) |
| June 2017 | - | $9.28 M(-39.0%) |
| Mar 2017 | - | $15.22 M(-30.9%) |
| Dec 2016 | $22.02 M(-42.2%) | $22.02 M(-31.2%) |
| Sept 2016 | - | $32.01 M(-5.1%) |
| June 2016 | - | $33.74 M(+0.5%) |
| Mar 2016 | - | $33.55 M(-11.9%) |
| Dec 2015 | $38.10 M(+1207.3%) | $38.10 M(-0.6%) |
| Sept 2015 | - | $38.31 M(+2231.5%) |
| June 2015 | - | $1.64 M(-57.9%) |
| Mar 2015 | - | $3.90 M(+33.9%) |
| Dec 2014 | $2.91 M | $2.91 M(-9.3%) |
| Sept 2014 | - | $3.21 M(-57.2%) |
| June 2014 | - | $7.50 M(-25.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $10.01 M(-11.1%) |
| Dec 2013 | $11.26 M(-17.6%) | $11.26 M(+1.3%) |
| Sept 2013 | - | $11.11 M(+19.4%) |
| June 2013 | - | $9.30 M(+0.2%) |
| Mar 2013 | - | $9.29 M(-32.0%) |
| Dec 2012 | $13.66 M(-83.7%) | $13.66 M(+5.7%) |
| Sept 2012 | - | $12.93 M(-20.5%) |
| June 2012 | - | $16.26 M(-69.0%) |
| Mar 2012 | - | $52.40 M(-37.5%) |
| Dec 2011 | $83.84 M(-51.0%) | $83.84 M(-14.2%) |
| Sept 2011 | - | $97.73 M(-11.9%) |
| June 2011 | - | $110.92 M(-16.0%) |
| Mar 2011 | - | $131.99 M(-22.8%) |
| Dec 2010 | $170.94 M(-31.7%) | $170.94 M(-9.0%) |
| Sept 2010 | - | $187.90 M(-9.1%) |
| June 2010 | - | $206.76 M(-3.8%) |
| Mar 2010 | - | $214.87 M(-14.2%) |
| Dec 2009 | $250.39 M(+508.1%) | $250.39 M(+575.3%) |
| Sept 2009 | - | $37.08 M(-1.9%) |
| June 2009 | - | $37.81 M(-0.6%) |
| Mar 2009 | - | $38.06 M(-7.6%) |
| Dec 2008 | $41.18 M(-13.1%) | $41.18 M(-5.6%) |
| Sept 2008 | - | $43.60 M(-3.2%) |
| June 2008 | - | $45.02 M(-3.1%) |
| Mar 2008 | - | $46.47 M(-1.9%) |
| Dec 2007 | $47.38 M(+189.4%) | $47.38 M(+21.0%) |
| Sept 2007 | - | $39.15 M(+145.5%) |
| June 2007 | - | $15.95 M(+19.0%) |
| Mar 2007 | - | $13.41 M(-18.1%) |
| Dec 2006 | $16.37 M(-91.4%) | $16.37 M(+1.6%) |
| Sept 2006 | - | $16.12 M(-0.1%) |
| June 2006 | - | $16.13 M(-92.0%) |
| Mar 2006 | - | $201.93 M(+6.0%) |
| Dec 2005 | $190.48 M(+5.1%) | $190.48 M |
| Dec 2004 | $181.17 M(+31.1%) | - |
| Dec 2003 | $138.19 M(+17.4%) | - |
| Dec 2002 | $117.71 M(+87.8%) | - |
| Dec 2001 | $62.66 M | - |
FAQ
- What is Catalyst Biosciences annual total liabilities?
- What is the all time high annual total liabilities for Catalyst Biosciences?
- What is Catalyst Biosciences quarterly total liabilities?
- What is the all time high quarterly total liabilities for Catalyst Biosciences?
What is Catalyst Biosciences annual total liabilities?
The current annual total liabilities of CBIO is $50.13 M
What is the all time high annual total liabilities for Catalyst Biosciences?
Catalyst Biosciences all-time high annual total liabilities is $250.39 M
What is Catalyst Biosciences quarterly total liabilities?
The current quarterly total liabilities of CBIO is $6.45 M
What is the all time high quarterly total liabilities for Catalyst Biosciences?
Catalyst Biosciences all-time high quarterly total liabilities is $250.39 M